📊 AI Stock Rating — Summary

Medical Properties Trust reported a revenue of $237.5 million with a net income loss of $16.5 million for the quarter ending September 30, 2025. This resulted in a negative EPS of $-0.0283. The company maintained a steady dividend payment of $0.08 per quarter, signaling commitment to shareholder returns despite financial challenges. The total assets stood at approximately $14.92 billion, against total liabilities of $10.26 billion, yielding equity of $4.66 billion and a significant net debt of $9.22 billion. The balance sheet shows a high leverage ratio, with a total debt-to-equity ratio above 2. Operating and free cash flow figures were not reported for the period, highlighting possible liquidity management issues. With 12-month analyst price targets ranging from $5 to $27 and a median consensus of $8.25, investment sentiment varied with a leaning towards further potential downside risk. Lack of positive price momentum over the past year was noted, but substantial dividend payouts partially offset the effect on total returns.

AI Score Breakdown

Revenue Growth — Score: 4/10

Revenue growth appears stagnant with the latest figure at $237.5 million. The lack of substantial growth rate suggests challenges in expanding operations or scaling business efficiently.

Profitability — Score: 3/10

The firm posted a net loss of $16.5 million, and negative EPS. Operating efficiency is under pressure, evidenced by continued losses.

Cash Flow Quality — Score: 2/10

No operating cash flow or free cash flow was reported, indicating potential liquidity issues. Dividend payments were sustained, which suggests reliance on other financing means.

Leverage & Balance Sheet — Score: 3/10

The company is significantly leveraged with net debt of $9.22 billion against equity of $4.66 billion. Financial resilience is a concern due to high indebtedness.

Shareholder Returns — Score: 5/10

Dividends remain consistent, offering $0.32 annually. However, price performance is lackluster, and absent meaningful price appreciation, total shareholder return is moderate.

Analyst Sentiment & Valuation — Score: 4/10

Valuation metrics are largely absent, but mixed analyst sentiment with a median target of $8.25 indicates caution. The stock may be perceived as undervalued or carrying risk, contingent on sentiment flux.

⚠ AI-generated — informational only, not financial advice.